IL2 and cancer: Importantly, among the various types of activated CD8 T cells, multifunctional CD8+ T cells capable of simultaneously producing multiple effector Th1 cytokines and cytotoxic markers (IFN-γ, TNF-α, IL-2, and CD107a) have been associated with higher protective efficacy in cancer immunotherapy and vaccination [29,30].